Introduction
Managing blood sugar around mealtimes is an important part of diabetes care. Many people with diabetes require rapid-acting insulin to help control the rise in blood glucose that occurs after eating as part of an individualized treatment plan.
Merilog is a rapid-acting insulin biosimilar approved to improve glycemic control in adults and pediatric patients with diabetes mellitus. Administered shortly before meals, it helps lower post-meal blood sugar levels. It is typically used alongside an intermediate-acting or long-acting insulin as part of a comprehensive diabetes management plan.
Because Merilog is a prescription insulin, treatment costs may vary depending on insurance coverage and the delivery system prescribed. Many people search for the Merilog SoloStar® patient assistance program to reduce their prescription costs. Prescription assistance programs such as those accessed through Prescription Hope may help eligible patients obtain Merilog SoloStar® at a more affordable cost.
What Is the Merilog SoloStar® Patient Assistance Program?
Understanding Merilog Prescription Assistance
While researching Merilog financial assistance, some patients may have come across the Merilog SoloStar® patient assistance program. But what exactly is a patient assistance program?
Some Pharmaceutical manufacturers have recognized that the cost of their brand-name medications is taking a toll on struggling Americans. The manufacturers have come up with a solution to this problem: patient assistance programs. Through these patient assistance programs, qualified patients get access to the name-brand medication they need at a lower cost than retail price. This means that qualified patients can get help paying for Merilog SoloStar® through pharmaceutical manufacturers.
The downside to these patient assistance programs is that they have a reputation for requiring a lot of documentation, communication with the manufacturer, and a litany of other administrative responsibilities. This can cause added stress, frustration, and a sense of being overwhelmed by the process.
But Prescription Hope can help!
How Expert Advocates Help Make Merilog SoloStar® More Affordable
Personalized Medication Assistance
Prescription Hope’s Merilog SoloStar® enrollment assistance allows qualified patients access to affordable name-brand medication they need at a low cost.
Our compassionate team of patient advocates understands the difficulty of applying to a prescription assistance program and helps you with any administrative needs during the process. Some of our patient support services include managing forms, documents, and signatures, communication with healthcare providers, coordinating with manufacturers, and more.
Ongoing Patient Support
Prescription Hope also offers long-term medication assistance and patient-centered support throughout the time that you are a patient with us. We understand that chronic conditions often require treatment continuity, so we offer services such as refill scheduling, document updates, yearly renewals, program monitoring, and more.
Navigating Diabetes Treatment Costs
While diabetes can be a frustrating condition to treat, your ability to get Merilog SoloStar® cost assistance doesn’t have to be. Insulin cost assistance is just one of the modes of prescription cost help that Prescription Hope offers to their qualified patients.
Qualified patients have full access to our patient support services at a simple monthly rate of $70.00 per month, per medication. This price means no hassles, hidden fees, or add-ons– no matter what medication you get approved for.
Even if you don’t qualify for a patient assistance program, we can still help you save. Our team will help you search for other ways to alleviate the financial burden of your intended name-brand medication, such as substitute medications, discount cards, and coupons. If we can’t help you save money, you pay us nothing!
Merilog SoloStar® Patient Assistance Eligibility
General Eligibility Requirements
Patients looking to enroll in a patient assistance program for Merilog SoloStar® need to understand Merilog SoloStar® patient assistance qualifications. Prescription Hope can keep you informed about program criteria and who qualifies for Merilog SoloStar® assistance. However, most programs normally set requirements in some specific areas:
Income: Each program sets its own qualifications for what a qualified patient’s income status should be.
Insurance: Each program also sets its own qualifications for what a qualified patient’s insurance coverage status should be.
Prescription: Every prescription assistance program requires a valid prescription for the patient’s intended name-brand medication.
U.S. Residency: In order to qualify, patients must be legal residents of the United States.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Are you looking for help with the Merilog SoloStar® application process? Does the idea of navigating the Merilog SoloStar® application process seem daunting? Prescription Hope is ready to help you access prescription support services in 6 easy steps:
- Submit Information: Our online enrollment form takes just a few minutes out of your day to complete.
- Advocate Contact: After we receive your online enrollment form, a patient advocate will contact you in 1-2 business days.
- Document Collection: After your prequalification, our team will collect any necessary documents.
- Provider Coordination: We will also coordinate with your provider to obtain any signatures that are needed.
- Program Submission: We will put everything in order and send in your application for you, while continuing to coordinate with the pharmaceutical manufacturer.
- Medication Delivery: Following approval, qualified patients normally receive their medications in 1-2 weeks.
Prescription Hope is not a pharmaceutical manufacturer or pharmacy. We do not handle any medications. Therefore, all medications are shipped directly from the pharmaceutical manufacturer to the patient’s door or doctor’s office.
Understanding Merilog
How Merilog Works
Merilog contains insulin aspart-szjj, a rapid-acting human insulin analog.
Insulin aspart-szjj lowers blood glucose by facilitating cellular glucose uptake, inhibiting hepatic glucose production, and suppressing lipolysis and proteolysis.
Following subcutaneous injection, insulin aspart begins lowering blood glucose quickly, helping reduce mealtime blood sugar spikes. Merilog has been demonstrated to be biosimilar to NovoLog® (insulin aspart), meaning there are no clinically meaningful differences in safety, purity, or potency from the reference product.
What Conditions Does Merilog Treat?
Merilog is FDA-approved to improve glycemic control in adults and pediatric patients with diabetes mellitus.
Merilog is a rapid-acting insulin intended to help control blood glucose elevations associated with meals. It is commonly used as part of an insulin regimen that may also include an intermediate-acting or long-acting insulin, depending on the individual’s treatment plan.
Merilog is the first FDA-approved rapid-acting insulin biosimilar in the United States.
Benefits of Treatment
For appropriate patients with diabetes, Merilog may:
- Improve overall glycemic control
- Reduce post-meal (postprandial) blood glucose elevations
- Provide rapid mealtime insulin coverage
- Be used in adults and children with diabetes mellitus
- Offer a biosimilar alternative to NovoLog® for appropriate patients when prescribed by a healthcare provider
Insulin therapy should always be individualized based on blood glucose monitoring, diet, activity level, and other patient-specific factors.
Important Safety Information and Side Effects
Merilog SoloStar® does not carry an FDA Boxed Warning.
Contraindications
Merilog is contraindicated:
- During episodes of hypoglycemia
- In patients with hypersensitivity to insulin aspart products or any component of Merilog
The most commonly reported adverse reactions include:
- Hypoglycemia (low blood sugar)
- Injection site reactions
- Lipodystrophy
- Localized cutaneous amyloidosis
- Weight gain
- Swelling of the hands or feet (peripheral edema)
- Rash
Other insulin-related adverse reactions may include:
- Hypersensitivity reactions
- Hypokalemia
Patients should notify their healthcare provider if side effects become severe or persistent.
Patients should discuss the following risks with their healthcare provider:
- Severe hypoglycemia
- Hyperglycemia or hypoglycemia when changing insulin regimens
- Hyperglycemia and diabetic ketoacidosis resulting from inadequate insulin dosing or interruption of therapy
- Medication errors caused by confusing different insulin products
- Serious hypersensitivity reactions, including anaphylaxis
- Hypokalemia
- Fluid retention and heart failure when used with PPAR-gamma agonists (such as thiazolidinediones)
- Lipodystrophy and localized cutaneous amyloidosis from repeated injections into the same site
- Never sharing a Merilog SoloStar® prefilled pen between patients, even if the needle is changed
Patients should carefully follow prescribed dosing instructions and monitor blood glucose regularly to reduce the risk of serious complications.
Available data with insulin aspart have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Maintaining good glycemic control before and during pregnancy is important to reduce diabetes-related risks.
Insulin is present in human milk. Available information suggests insulin therapy is compatible with breastfeeding, although insulin requirements may change during lactation. Patients should discuss insulin dose adjustments with their healthcare provider.
Merilog may interact with:
- Other antidiabetic medications
- Corticosteroids
- Diuretics
- ACE inhibitors
- MAO inhibitors
- Beta-blockers (may mask symptoms of hypoglycemia)
- Sympatholytic medications (may mask signs and symptoms of hypoglycemia)
- Alcohol
- Pentamidine
- Clonidine
- Lithium salts
- Thiazolidinediones (may increase the risk of heart failure when combined with insulin)
Patients should inform their healthcare provider about all prescription medications, over-the-counter medicines, vitamins, and herbal supplements before starting treatment.
Merilog is administered by subcutaneous injection and should be injected within 5 to 10 minutes before a meal. It is available as a Merilog SoloStar® 3 mL prefilled pen (100 units/mL) and a 10 mL multidose vial (100 units/mL). Injection sites include the abdomen, thigh, upper arm, and buttocks, and sites should be rotated to reduce the risk of lipodystrophy and localized cutaneous amyloidosis. Merilog is generally used as part of a treatment regimen that also includes an intermediate-acting or long-acting insulin. It should not be mixed with other insulins when administered by continuous subcutaneous insulin infusion (insulin pump). When administered by subcutaneous injection, mixing instructions should follow the FDA-approved prescribing information and healthcare provider guidance.
Access to Multiple Medications
Support Beyond Merilog SoloStar®
Are you in need of further help with your prescription medication access? Are you in need of multiple medication assistance programs? Look no further than Prescription Hope!
Our prescription medication access services are available for hundreds of name-brand medications and their associated patient assistance programs. This means that every name-brand medication a qualified patient needs can be obtained at the same low service rate of $70.00 per month, per medication.
Why Choose Prescription Hope
Patient-Focused Medication Support
For 20 years, Prescription Hope has offered prescription affordability support and patient-centered prescription help to qualified patients across the nation. We are proud to say that we offer Merilog SoloStar® assistance through Prescription Hope.
Simplified Access to Prescription Medications
Prescription Hope offers all their medication access support and patient assistance services for a low monthly cost of $70.00 per month, per medication. There are no add-ons, no medication costs, no long contracts, and no hidden fees.
Ongoing Prescription Assistance
Prescription Hope’s help with prescription affordability programs doesn’t end when you receive your medication. We come by your side throughout treatment, offering our qualified patients long-term medication support. We continue to manage all administrative tasks to assist your continued status with a patient assistance program, such as refill scheduling, document updates, yearly renewals, and more.
Network Access
Our network extends across hundreds of name-brand medications and the patient assistance programs that go with them, offering you access to whatever medication you may need.
If you need Merilog SoloStar® and you don’t know how you’re going to afford it, enroll with Prescription Hope to see how we can help you save money today!